Low-Molecular-Weight Heparin in Acute Coronary Syndromes

By  

Heart Drug, Vol. 4, Iss. 3, 2004-08 ,pp. : 111-118

Karger

Access to resources Recommend Favorite

Managing high-risk patients with acute coronary syndromes: the Prospective Registry of Acute Ischaemic Syndromes in the UK (PRAIS-UK)

By Collinson J.   Perez de Arenaza D.   Flather M.D.   Bakhai A.   Adgey A.A.J.    

Clinical Medicine, Vol. 4, Iss. 4, 2004-07 ,pp. : 369-375

Royal College Of Physicians

Access to resources Recommend Favorite

Use of Unfractionated Heparin and a Low-Molecular-Weight Heparin following Thrombolytic Therapy for Acute ST-Segment Elevation Myocardial Infarction

By Wang Xu-Kai   Zhang Ye   Yang Cheng-Ming   Wang Yan   Liu Guang-Yao  

Clinical Drug Investigation, Vol. 26, Iss. 6, 2006-01 ,pp. : 341-349

Adis International

Access to resources Recommend Favorite

Pellets for oral administration of low-molecular-weight heparin

By Scala-Bertola Julien   Gajdziok Jan   Rabišková Miloslava   Bonneaux François   Lecompte Thomas   Sapin Anne   Maincent Philippe  

Drug Development and Industrial Pharmacy, Vol. 35, Iss. 12, 2009-12 ,pp. : 1503-1510

Informa Healthcare

Access to resources Recommend Favorite

Low molecular weight heparin in acute stroke

By Bath P.M.  

Expert Opinion on Investigational Drugs, Vol. 7, Iss. 8, 1998-08 ,pp. : 1323-1330

Informa Healthcare

Access to resources Recommend Favorite